Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism

Journal of Nutrition

Volumn 132, Issue 9, 2002, Pages 2605-2608

  Khalil, Dania A ^a   Lucas, Edralin A ^a   Juma, Shanil ^a   Smith, Brenda J ^a   Payton, Mark E ^a   Arjmandi, Bahram H ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Age; Bone; Isoflavones; Men; Selective estrogen receptor modulators

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE; ESTRADIOL; ISOFLAVONE; MILK PROTEIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN C; SOYBEAN PROTEIN;

ADULT; AGED; AGING; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; DIETARY INTAKE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; SOYBEAN; URINE LEVEL;

GLYCINE MAX;

EID: 0036712564     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.9.2605     Document Type: Article

References (40)

1. Idiopathic osteoporosis in men
2. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men
3. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
4. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease
5. Soy isoflavones: Benefits and risks from nature's selective estrogen receptor modulators (SERMs)
6. Phytoestrogens: The "natural" selective estrogen receptor modulators?
7. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
8. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women
9. Isoflavone effects on bone mineral content (BMC) and bone mineral density (BMD) in young adult women
10. New developments in biochemical markers of osteoporosis
11. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease
12. Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption
13. Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3
14. Insulin-like growth factor I as a predictor of cortical bone mass in a long-term study of ovariectomized and estrogen-treated rats
15. Relationship between baseline IGF-I and femoral bone density in women aged over 70 years: Potential implications for prevention of age-related bone loss
16. Hip fractures: A worldwide problem today and tomorrow
17. Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction
18. Regulatory effects of IGF-I and IGF-II on bone collagen synthesis in rat calverial culture
19. Insulin-like growth factor-I (IGF-I) is required for the anabolic action of parathyroid hormone (PTH) on bone
20. Insulin-like growth factor-I in men with idiopathic osteoporosis
21. Insulin-like growth factors and bone: The osteoporosis connection
22. Osteoporosis in men: A cellular endocrine perspective of an increasingly common clinical problem
23. Response of bipotential human marrow stromal cells to insulin-like growth factors: Effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes
24. Effect of locally infused IGF-I on femoral gene expression and bone turnover activity in old rats
25. Effect of estrogen deficlency on IGF-I plasma levels: Relationship with bone mineral density in premenopausal women
26. Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: Relationship with bone mineral density and lipid metabolism in perimenopausal women
27. Association between insulin-like growth factor I and bone mineral density in older women and men: The Framingham Heart Study
28. Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women
29. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
30. Age-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I: Potential implications for age-related (type II) osteoporotic fracture occurrence
31. Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells
32. Soy isoflavones osteoprotective role in postmenopausal women: Mechanism of action
33. Effects of soy protein on bone metabolism
34. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women
35. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women
36. The role of soy protein with normal or reduced isoflavone content in reversing ovarian hormone deficiency induced bone loss in rats
37. The bone modulating effect of soy protein in ovarian hormone deficiency is related to its isoflavone content
38. Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men